Navigation Links
Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009
Date:4/14/2009

NORMAN, Okla., April 14 /PRNewswire/ -- Aaron's Bridge presents Autism Research Institute's Defeat Autism Now!(R) Regional Conference June 13-14, 2009, at The Embassy Suites Hotel and Convention Center at 2501 Conference Drive in Norman. The conference will feature seminars devoted to educating doctors, parents and professionals. Presenters including Elizabeth Mumper, MD; Bryan Jepson, MD; Dan Rossignol, MD; and Doreen Granpeesheh, PhD, will discuss topics such as behavioral and biomedical strategies, dietary interventions, what parents can do now and hands-on workshops for implementing treatment strategies.

On June 14, a Clinician Introductory Workshop with CME Credits will cover topics such as case histories, medical treatment strategies for gut disease and autism, integration of science and biomedical interventions for autism. A complimentary lunch will be provided by Aaron's Bridge.

"Autism is a challenge for pediatricians, their patients and families. By working together, we stand the best chance of helping these children to realize their full potential," American Academy of Pediatrics President Renee R. Jenkins, MD, FAAP said this past April. "The Academy is committed to working with researchers and treatment groups like Defeat Autism Now!(R) to get closer to finding answers to the multiple causes of autism and determining effective therapies."

Defeat Autism Now!(R) is distinguished by its commitment to invite only the most credible, accredited and forward-thinking researchers and clinicians as speakers.

The conference is sponsored by Aaron's Bridge. Keith and Joni Geary established Aaron's Bridge foundation because of their personal experience with autism. Their son, Aaron, was diagnosed with autism at age 3, and the family began to see promising improvements in his condition when he began biomedical treatments with Dr. Bryan Jepson at The Thoughtful House Center for Children in Aus
'/>"/>

SOURCE Aaron?s Bridge
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
2. First Annual Autism Conference at Packard Childrens and Stanford Brings Parents and Researchers Together
3. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
4. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
5. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
6. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
7. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
8. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
10. New Regional Biotech Association Formed
11. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...., Dec. 2 TechConnect World, an ev...velopment and product integration in cleantech, na...1th deadline for technology abstracts and business...nnect World, in association with the Nano Science ...hnology and Sustainable Industries Organization (C...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutic... ), a leading pharmaceutical company,specializing ...f branded,generic and proprietary pharmaceuticals ...ve been included in China,s National Drug Reimburs...inistry of Human Resources and Social,Security on ...
(Date:12/2/2009)...2 According to the National Instit...ns diagnosed with diabetes already have some stage...amage to the retina caused by leaky blood vessels,...etes and is one of the most feared diabetic compli...s who,ve had diabetes for 10 years or more will ex...
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Industrial Enzymes - A Global Mar...64431/Industrial-Enzymes---A-Global-Market-Report....oly with few strong players and a host of small su...ompetition and commoditization characterize the in...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
... Institute of Aeronautics and Astronautics has pub...e , that compiles for the first time the emerging ... drives, warp drives, gravity control, and faster-...ionize spaceflight and enable human voyages to oth...sound like science fiction, authors Marc Millis an...
...armaceuticals, Inc. (Nasdaq: ALXA ) announced to...will present during the 11th Annual BIO CEO & ...at 2:45 p.m. ET. The presentation,will be webcast... To access the presentation via the Web, pleas...com or at, http://www.corporate-ir.net/ireye/conf...
...alth,Inc. (Nasdaq: GHDX ) today reported financi...arter and year ended December 31, 2008. , Tota... to $31.2 million,compared with $19.3 million in t...he Oncotype DX(R) breast cancer assay was $30.9 mi...f 60 percent, compared with $19.3 million in the,f...
Other Biology Technology:New book from AIAA explores space drives, warp drives 2Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference 2Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 2Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 4Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 5Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 6Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 7Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 8Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 9
(Date:12/2/2009)...wswire/ -- DigitalPersona, Inc., a leader in finge...y announced an agreement with IBM to deploy a new ...technology on IBM SurePOS 500 retail systems. The ...s point-of-sale applications to more easily and qu... can be linked to the individuals who perform them...
(Date:12/2/2009)...a and another from Yale University have shown that...f Acanthodactylus beershebensis , a lizard specie...g to the study, these reptiles move less and catch...pressure from predators. , Many theoretical mode...had been very few experimental trials and none in ...
(Date:12/1/2009)...unce the publication of results from its Phase II ...rability of its novel, intranasal drug/device prod...sitis with nasal polyps in Rhinology , the offici...logic Societies. , Chronic rhinosinusitis with ...cantly reduce a patient,s quality of life, causing...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Lizards change their diet to avoid predators 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 1Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 2Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 3Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 1Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 2Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 3Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 5Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 6Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 7Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 8Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 9AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 1AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 2AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 3AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 4AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 5
...ife boils down to two basic missions: eat, and avo...a tadpole eats, the faster it grows big enough to ...eing active, which ups the odds of becoming someon...ey adjust their activity levels in response to pre...ichigan graduate student shows that internal facto...
...cal Center researchers have discovered how the bra...he nose. , In studies in mice, the researchers fou...-- the first stop for information from the nose --...objects, such as the fragrance of a blooming rose....e host of chemical compounds that comprise a rose,...
...ble doctors to predict which smokers using the nic...unt of cravings and have the highest probability o... results of a study in the June issus of the Journ...The blood test, which is a measure of the rate at ...erformed non-invasively using saliva or urine samp...
Other Biology News:Time of day tempers tadpoles' response to predators 2Researchers show how brain decodes complex smells 2Blood test predicts success of quitting smoking using the nicotine patch 2
...olabeled Ligands\n\nReceptor-related research has ... new radiolabeled ligands selected to keep pace wi...e of products and services for receptor research a...-art radioligands. If you do not find exactly what...
Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
iTaq DNA Polymerase, 5,000 U from Bio-Rad
Rabbit Anti-hnRNP-U Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: